Centiva Capital, LP Deciphera Pharmaceuticals, Inc. Transaction History

Centiva Capital, LP

  • $4.79 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021
SELL
$40.39 - $56.73 $144,394 - $202,809
-3,575 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$51.77 - $66.18 $185,077 - $236,593
3,575 New
3,575 $204,000
Q3 2020

Nov 16, 2020
SELL
$43.8 - $58.16 $152,380 - $202,338
-3,479 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$37.05 - $65.03 $128,896 - $226,239
3,479 New
3,479 $208,000

Others Institutions Holding DCPH

# of Institutions
6
Shares Held
293K
Call Options Held
500
Put Options Held
0
View Full List

About Deciphera Pharmaceuticals, Inc.

DCPH Quotes by TradingView
  • Ticker DCPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,822,100
  • Description
  • Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...
More about DCPH
Track This Portfolio

Track Centiva Capital, LP Portfolio

Follow Centiva Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Centiva Capital, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email